Cover ImageSALE
市場調查報告書

生物晶片的全球市場:2017年∼2021年

Global Biochip Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 547897
出版日期 內容資訊 英文 79 Pages
訂單完成後即時交付
價格
Back to Top
生物晶片的全球市場:2017年∼2021年 Global Biochip Market 2017-2021
出版日期: 2017年08月22日 內容資訊: 英文 79 Pages
簡介

全球生物晶片市場,預計2017年∼2021年以17.53%的年複合成長率成長。

本報告提供全球生物晶片市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 調查範圍

第3章 調查手法

第4章 簡介

第5章 生物晶片的全球市場:各製造技術

  • 微陣列
  • 微射流

第6章 生物晶片的全球市場:各地區

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第7章 決策組成架構

第8章 推動因素與課題

第9章 市場趨勢

第10章 業者情勢

  • 競爭模式
  • 投資機會

第11章 主要供應商分析

  • Agilent Technologies
  • GE Healthcare
  • PerkinElmer
  • Thermo Fisher Scientific
  • 其他卓越供應商

第12章 附錄

第13章 關於Technavio

目錄
Product Code: IRTNTR14503

About Biochip

Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. In simple terms, biochips are small sized chips that can perform multiple (generally thousands) biochemical reactions parallelly. A collection of microarrays or micro-test sites form these biochips. Microarrays when arranged on a surface made up of either glass or silicon, can perform large numbers of tests at the same. Thus, they help in cost and time saving.

Technavio's analysts forecast the global biochip market to grow at a CAGR of 17.53% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global biochip market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • APAC
  • Europe
  • North America
  • ROW

Technavio's report, Global Biochip Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • Agilent Technologies
  • Illumina
  • PerkinElmer
  • Thermo Fisher Scientific

Other Prominent Vendors

  • BioChain
  • Bio-Rad Laboratories
  • Cepheid
  • EMD Millipore
  • Fluidigm
  • SuperBioChips Laboratories
  • US Biomax

Market driver

  • Increase in market presence with collaboration strategy
  • For a full, detailed list, view our report

Market challenge

  • Standardization and accuracy issues
  • For a full, detailed list, view our report

Market trend

  • Growth in bioinformatics software industry
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline
  • Market size and forecast
  • Five forces analysis

PART 05: Market segmentation by fabrication technology

  • Global biochip market by microarrays
  • Global biochip market by microfluidics

PART 06: Geographical segmentation

  • Biochip market in Americas
  • Biochip market in EMEA
  • Biochip market in APAC

PART 07: Decision framework

PART 08: Drivers and challenges

  • Market drivers
  • Market challenges

PART 09: Market trends

  • Increasing POC diagnostics
  • Growing application of biochips in pharmacogenomics
  • Rise in vendors' strategic initiatives
  • Increasing use of biochip technology as alternative to animal testing

PART 10: Vendor landscape

  • Competitive scenario
  • Investment opportunity

PART 11: Key vendor analysis

  • Agilent Technologies
  • GE Healthcare
  • PerkinElmer
  • Thermo Fisher Scientific
  • Other prominent vendors

PART 12: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Types of biochips and their applications
  • Exhibit 02: The biochip platform
  • Exhibit 03: Global biochip market: Overview
  • Exhibit 04: Global biochip market 2016-2021 ($ billions)
  • Exhibit 05: Significance of biochip in different sectors
  • Exhibit 06: Factors impacting global biochip market
  • Exhibit 07: Five forces analysis
  • Exhibit 08: Global biochip market by fabrication technology 2016-2021 (% share)
  • Exhibit 09: Global biochip market by fabrication technology: Snapshot
  • Exhibit 10: Global biochip market by microarrays 2016-2021 ($ billions)
  • Exhibit 11: Applications of DNA microarrays
  • Exhibit 12: Global biochip market by microfluidics 2016-2021 ($ billions)
  • Exhibit 13: Applications of lab-on-a-chip
  • Exhibit 14: Global biochip market by geography 2016-2021 (% share)
  • Exhibit 15: Global biochip market by geography: Snapshot
  • Exhibit 16: Growth perspective in developed and developing market
  • Exhibit 17: Biochip market in Americas 2016-2021 ($ billions)
  • Exhibit 18: Programs held by companies in global biochip market
  • Exhibit 19: Biochip market in EMEA 2016-2021 ($ billions)
  • Exhibit 20: Biochip market in APAC 2016-2021 ($ billions)
  • Exhibit 21: Biochips in testing agriculture products
  • Exhibit 22: Major chronic disease-related deaths 2012 (in thousands)
  • Exhibit 23: Strategic success factors for vendors
  • Exhibit 24: Investment opportunity mapping
  • Exhibit 25: Agilent Technologies: Profile
  • Exhibit 26: Agilent Technologies: Strength analysis
  • Exhibit 27: Agilent Technologies: Strategy assessment
  • Exhibit 28: Agilent Technologies: Opportunity assessment
  • Exhibit 29: GE Healthcare: Profile
  • Exhibit 30: GE Healthcare: Strength analysis
  • Exhibit 31: GE Healthcare: Strategy assessment
  • Exhibit 32: GE Healthcare: Opportunity assessment
  • Exhibit 33: PerkinElmer: Profile
  • Exhibit 34: PerkinElmer: Strength analysis
  • Exhibit 35: PerkinElmer: Strategy assessment
  • Exhibit 36: PerkinElmer: Opportunity assessment
  • Exhibit 37: Thermo Fisher Scientific: Profile
  • Exhibit 38: Thermo Fisher Scientific: Strength analysis
  • Exhibit 39: Thermo Fisher Scientific: Strategy assessment
  • Exhibit 40: Thermo Fisher Scientific: Opportunity assessment
Back to Top